2011
DOI: 10.1208/s12249-011-9725-8
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Characterization of Chitosan Gels for Buccal Delivery of Celecoxib: Influence of a Penetration Enhancer

Abstract: Abstract. Celecoxib (Cx) shows high efficacy in the treatment of osteoarthritis and rheumatoid arthritis as a result of its high specificity for COX-2, without gastrolesivity or interference with platelet function at therapeutic concentrations. Besides of anti-inflammatory effects, Cx also has a potential role for oral cancer chemoprevention. For these conditions, oral administration in long-term treatment is a concern due to its systemic side effects. However, local application at the site of injury (e.g., bu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
48
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(49 citation statements)
references
References 50 publications
1
48
0
Order By: Relevance
“…CXB is highly lipophilic (logP value of 4.21), and could be retained in superficial skin layers (1). Very lipophilic drugs enter into the stratum corneum, but these drugs remain in this superficial layer and do not reach the deep layers of the skin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CXB is highly lipophilic (logP value of 4.21), and could be retained in superficial skin layers (1). Very lipophilic drugs enter into the stratum corneum, but these drugs remain in this superficial layer and do not reach the deep layers of the skin.…”
Section: Discussionmentioning
confidence: 99%
“…CXB also has chemopreventive activity against some types of cancer, such as ultraviolet B radiation-induced skin cancer and breast cancer. The activity of CXB is due to the selective inhibition of cyclooxygenase (COX-2) activity (1)(2)(3). Currently, CXB is marketed in a conventional capsule form for oral administration.…”
Section: Introductionmentioning
confidence: 99%
“…Cid et al [89] explored chitosan gels for buccal delivery of the highly lipophilic celecoxib, a COX-2 inhibitor, for oral cancer chemoprevention. Laurocapram (Azone ® ), a nonionic surfactant, was added to this formulation as a penetration enhancer in order to increase uptake of the drug in the buccal mucosa.…”
Section: Oral Cancermentioning
confidence: 99%
“…To overcome these challenges, bioadhesive formulations are designed to reduce the frequency of administrations and improve patient compliance. The excellent property of chitosan can not only improve adhesion to the mucosa but also enhance the permeation of drugs (Senel et al 2000;Cid et al 2012). Chitosan gels containing transforming growth factor-β (TGF-β) were used for mucosal drug delivery and the permeability of TGF-β across buccal mucosa was increased by six fold (Senel et al 2000).…”
Section: Oral Deliverymentioning
confidence: 99%